v3.26.1
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)
12 Months Ended
Dec. 31, 2025
Disclosure of detailed information about financial instruments [abstract]  
The accounting balances of financial assets and liabilities represent a reasonable approximation of fair value The Company uses the following classification to categorize its financial instruments and their respective hierarchy levels:
Level12/31/202512/31/2024
FINANCIAL ASSETS
Amortized cost27,559,236 39,017,827 
Cash and cash equivalents16,417,860 26,572,522 
Accounts receivable, net6,098,448 6,513,888 
Restricted cash4,097,063 3,679,483 
Reimbursement rights754,672 1,613,335 
Loans, financing and debentures191,193 638,599 
Fair value through result12,930,988 11,537,109 
Marketable securities211,421,280 8,967,937 
Beneficiary parties2435,235 417,242 
Derivative financial instruments21,074,473 2,151,930 
Fair value through other comprehensive income1,237,786 946,059 
Investments (Interests)11,175,539 861,234 
Derivative financial instruments 262,247 84,825 
FINANCIAL LIABILITIES
Amortized cost112,069,908 109,460,695 
Loans, financing and debentures61,034,561 59,297,533 
Obligations of Law No. 14,182/202143,766,663 42,022,123 
Suppliers3,927,925 2,764,288 
Compulsory loan – Agreements1,073,452 1,105,534 
RGR Returns695,705 932,250 
Reimbursement obligations357,460 70,803 
Shareholders compensation136,124 2,490,668 
Leases488,606 182,583 
Concessions payable - use of public property589,412 594,913 
Fair value through result15,064,322 17,500,976 
Loans, financing and debentures13,261,203 16,323,041 
Derivative financial instruments1,803,119 1,177,935 
Measurement of financial leveraging index
12/31/202512/31/2024
Total loans, financing and debentures74,295,764 75,620,574 
(+) Derivative financial instruments - debt protection728,646 (974,381)
(-) Marketable securities(11,856,515)(9,385,179)
(-) Cash and cash equivalents (16,417,860)(26,572,522)
Net debt46,750,035 38,688,492 
(+) Total shareholders’ equity118,501,657 121,999,776 
Total Capital165,251,692 160,688,268 
Financial leverage index (%)2824
Assumptions adopted
The table below analyzes, on a nominal basis, the Company’s non‑derivative financial liabilities by maturity ranges, corresponding to the remaining period from the balance sheet date through the final contractual maturity date. Contractual
maturity is based on the latest date on which the Company is required to settle the obligations and include the related contractual interest amounts, where applicable.
12/31/2025
Nominal payment flow
Up to 1 yearFrom 1 to 2 YearsFrom 2 to 5 YearsOver 5 YearsTotal
Financial Liabilities (Current / Non-Current)21,819,272 23,826,155 47,477,378 102,121,795 195,244,599 
Obligations under Law No. 14.182/20213,738,498 6,364,054 13,458,478 61,111,171 84,672,201 
Loans, financing and debentures13,204,167 17,295,202 33,703,903 40,598,177 104,801,449 
Suppliers3,916,279 10,347 — — 3,926,626 
RGR Returns695,705 — — — 695,705 
Shareholder Remuneration136,124 — — — 136,124 
Leases72,981 45,856 114,854 65,166 298,857 
Concessions payable UBP55,518 110,695 200,143 347,281 713,637 
12/31/2024
Nominal payment flow
Up to 1 yearFrom 1 to 2 YearsFrom 2 to 5 YearsOver 5 YearsTotal
Financial Liabilities (Current / Non-Current)22,599,741 22,968,512 41,394,062 97,366,345 184,328,660 
Obligations of Law No. 14,182/20212,953,184 3,439,353 12,906,745 62,908,147 82,207,429 
Loans, financing and debentures 13,769,529 18,913,993 28,317,110 34,133,371 95,134,003 
Suppliers2,756,329 7,959 — — 2,764,288 
RGR Returns492,276 439,974 — — 932,250 
Reimbursement Obligations 55,517 15,286 — — 70,803 
Shareholders remuneration 2,490,668 — — — 2,490,668 
Leases 31,192 20,183 29,536 41,971 122,882 
Concessions payable UBP51,046 131,764 140,671 282,856 606,337 
Schedule of derivative financial instruments Derivative financial instruments for hedging debt and firm commitments
MaturityNotional value12/31/202512/31/202412/31/202512/31/2024
AssetLiability
Debt protection derivative
Credit agreement - US$ vs CDI1/8/2025493,000 — 118,733 — — 
Bonds - US$ vs CDI2/4/20252,535,300 — 500,998 — — 
Credit agreement - US$ vs CDI8/29/2025219,150 — 54,290 — — 
Credit agreement - US$ vs CDI12/9/2025500,000 — 13,170 — — 
Credit agreement - EUR vs CDI12/23/2025500,000 — 5,245 — — 
Credit agreement - US$ vs CDI2/27/2026500,000 — — 42,071 — 
Credit agreement - US$ vs CDI8/11/2026350,000 — — 11,840 — 
Credit agreement - US$ vs CDI12/4/2026322,560 1,895 — — — 
Credit agreement - EUR vs CDI12/21/2026245,000 1,764 — — — 
Credit agreement - EUR vs CDI8/16/2027400,000 25,446 — 42,633 — 
Credit agreement - US$ vs CDI12/3/2027215,040 18,181 — 17,981 — 
Credit agreement - US$ vs CDI12/16/2027216,760 17,387 — 17,758 — 
Credit agreement - US$ vs CDI6/20/2029232,873 16,712 47,415 1,752 7,603 
Bonds - US$ vs CDI2/4/20303,810,300 428,933 715,544 355,301 235,194 
Debentures - IPCA vs CDI6/15/20314,900,000 331,658 142,788 279,429 343,924 
Debentures - IPCA vs CDI9/15/20341,630,000 87,849 — 103,383 89,867 
SACE - US$ vs CDI12/4/20342,378,400 — 266,397 207,039 185,005 
Bonds - US$ vs CDI1/11/20354,229,025 — 287,736 586,756 316,342 
Debentures - IPCA vs CDI7/16/20352,000,000 96,620 — 102,499 — 
Debentures - IPCA vs CDI9/17/2035700,000 48,028 — 34,677 — 
1,074,473 2,152,316 1,803,119 1,177,935 
Long-term commitment derivatives
NDF US$4/30/202567,113 — 224 — — 
NDF US$ and Primary Aluminum10/1/2025444 — 91 — — 
NDF US$ and Primary Aluminum11/1/2025447 — 92 — — 
NDF US$ and Primary Aluminum12/1/2025451 — 91 — — 
NDF US$ and Primary Aluminum2/1/202633,089 4,695 6,548 — — 
NDF US$2/27/20261,636 251 — — — 
NDF US$ and Primary Aluminum3/1/202658,884 8,312 11,635 — — 
NDF US$ and Primary Aluminum4/1/202659,296 8,191 11,684 — — 
NDF US$ and Primary Aluminum5/1/202659,718 8,316 11,752 — — 
NDF US$ and Primary Aluminum6/1/202660,181 8,313 11,726 — — 
NDF US$6/30/2026650 103 — — — 
NDF US$ and Primary Aluminum7/1/202660,617 8,338 11,751 — — 
NDF US$7/31/2026650 103 — — — 
NDF US$ and Primary Aluminum8/1/202661,081 8,354 11,852 — — 
NDF US$8/31/2026337 53 — — — 
NDF US$ and Primary Aluminum9/1/202634,560 5,098 6,993 — — 
NDF US$11/30/2026626 100 — — — 
NDF US$12/30/20261,487 238 — — — 
NDF US$1/29/20271,769 283 — — — 
NDF US$2/26/20271,395 224 — — — 
NDF US$3/31/20272,068 333 — — — 
NDF US$4/30/20271,665 269 — — — 
NDF US$5/31/20271,178 192 — — — 
NDF US$6/30/2027757 124 — — — 
NDF US$7/30/2027252 42 — — — 
NDF US$8/31/2027409 67 — — — 
NDF US$9/30/2027157 26 — — — 
NDF US$10/29/2027241 40 — — — 
NDF US$11/30/2027325 54 — — — 
NDF US$12/30/2027168 28 — — — 
NDF US$1/31/2028337 57 — — — 
NDF US$2/25/202884 14 — — — 
NDF US$3/31/2028168 29 — — — 
62,247 84,439   

Maturity12/31/202512/31/2024
Variation of fair value of the derivative— — 
Credit agreement - US$ vs CDI1/8/2025(11,948)109,356 
Bonds - US$ vs CDI2/4/2025(193,974)560,392 
Credit agreement - US$ vs CDI8/29/2025(44,993)52,930 
Credit agreement - US$ vs CDI12/9/2025(103,798)13,170 
Credit agreement - EUR vs CDI12/23/2025(38,697)5,245 
Credit agreement - US$ vs CDI2/27/2026(63,887)— 
Credit agreement - US$ vs CDI6/18/2026— 68,485 
Credit agreement - US$ vs CDI8/11/2026(11,840)— 
Credit agreement - US$ vs CDI12/4/20261,895 — 
Credit agreement - EUR vs CDI12/21/20261,764 — 
Credit agreement - EUR vs CDI8/16/2027(17,186)— 
Credit agreement - US$ vs CDI12/3/2027200 — 
Credit agreement - US$ vs CDI12/16/2027(371)— 
Credit agreement - US$ vs CDI6/20/2029(33,446)41,141 
Bonds - US$ vs CDI2/4/2030(700,988)634,410 
Debentures - IPCA vs CDI6/16/2031(88,822)(296,800)
Debentures - IPCA vs CDI9/15/2034(14,779)(89,867)
SACE - US$ vs CDI12/4/2034(500,256)81,392 
Bonds - US$ vs CDI1/11/2035(851,612)(28,606)
Debentures - IPCA vs CDI7/16/2035(5,879)— 
Debentures - IPCA vs CDI9/17/203513,351 — 
Derivative Result(2,665,266)1,151,248 
Variation of fair value of the protected debt
Credit agreement1/8/202510,718 (165,382)
Bonds2/4/2025122,640 (765,876)
Credit agreement8/29/202525,167 (68,059)
Credit agreement12/9/202536,360 (17,497)
Credit agreement12/23/2025(29,242)(7,838)
Credit agreement2/27/20262,664 — 
Credit agreement6/18/2026— (257,569)
Credit agreement8/11/2026(9,836)— 
Credit agreement12/4/2026(5,734)— 
Credit agreement12/21/2026(3,181)— 
Credit agreement8/16/2027(10,792)— 
Credit agreement12/3/2027(4,296)— 
Credit agreement12/16/2027(2,789)— 
Credit agreement6/20/202910,681 (59,203)
Bonds2/4/203048,287 (1,068,243)
Debentures6/16/2031(600,834)(53,596)
Debentures9/15/2034(211,489)46,824 
SPA (SACE)12/4/2034130,855 (206,217)
Bonds1/11/2035(122,379)(95,074)
Debentures7/16/2035(63,802)— 
Debentures9/17/20357,150 — 
Debt Result(669,852)(2,717,730)
Net Financial Result(3,335,118)(1,566,482)

12/31/202512/31/2024
Balance on January 123,257,512 6,757,343 
Designation of protected debt4,949,360 18,630,425 
Fair value assessment - result669,852 2,717,730 
Amortizations(6,012,836)(4,847,986)
Balance as of December 31st22,863,888 23,257,512 
12/31/202512/31/2024
Balance on January 1(1,058,820)283,908 
Fair value assessment - result2,665,266(1,151,248)
Fair value assessment - OCI22,146(84,825)
Amortizations(962,193)(106,655)
Balance as of December 31st666,399(1,058,820)
Impact of each scenario on company results, sensitivity analysis
Effect on result
Balance on
12/31/2025
Scenario I -
Probable 20261
Scenario II
(+25%)1
Scenario III
(+50%)1
CDILoans, financing and debentures(42,532,019)(5,167,640)(6,460,614)(7,753,587)
Financing and loans receivable— — — — 
Impact on the result(42,532,019)(5,167,640)(6,460,614)(7,753,587)
SELICLoans, financing and debentures— — — — 
AIC Reimbursement 54,774 6,710 8,386 10,067 
Impact on the result54,774 6,710 8,386 10,067 
TJLPLoans, financing and debentures(2,919,980)(264,842)(331,126)(397,409)
Impact on the result(2,919,980)(264,842)(331,126)(397,409)
IGPM (General Market Price Index)Leases(342,644)(13,534)(16,927)(20,319)
Financing and loans receivable— — — — 
Impact on the result(342,644)(13,534)(16,927)(20,319)
Obligations of Law No. 14,182/2021(43,766,663)(1,890,720)(2,363,400)(2,836,080)
IPCALoans, financing and debentures(21,028,085)(908,413)(1,135,517)(1,362,620)
Right of reimbursement699,898 30,236 37,794 45,353 
Impact on the result(64,094,850)(2,768,897)(3,461,123)(4,153,347)
Impact on profit or loss in case of assessment of national indexes(109,834,719)(8,208,203)(10,261,404)(12,314,596)
(1) Assumptions adopted:12/31/2025Likely+25%+50%
CDI14.90 12.15 15.19 18.23 
SELIC15.00 12.25 15.31 18.38 
TJLP8.05 9.07 11.34 13.61 
IGPM (General Market Price Index)-1.05 3.95 4.94 5.93 
IPCA4.32 4.32 5.40 6.48